Back to map
Auxilius Pharma

Auxilius Pharma

Hudson, United States
Series C+
Health & Life Sciences
Non-CEE with local presence

Auxilius Pharma is developing a reformulated extended-release medication for chronic stable angina that incorporates nicorandil as the active ingredient, aimed at effective symptom management with a once-daily dosing schedule. This product is designed to reduce the risk of drug tolerance while utilizing established safety and efficacy data through the 505(b)(2) regulatory pathway.

Founded

2018

Employees

7

Total Raised

$7M

Valuation

$29M

Open Positions (0)

No open positions at the moment